Cargando…
MMP-3 as a predictor for structural remission in RA patients treated with MTX monotherapy
BACKGROUND: The study was undertaken to assess the efficacy of methotrexate (MTX) monotherapy on the radiographic progression of individual rheumatoid arthritis (RA) patients, each of whom had received MTX monotherapy for 3 years with an option to change to biological disease-modifying anti-rheumati...
Autores principales: | Shiozawa, Kazuko, Yamane, Takashi, Murata, Miki, Yoshihara, Ryosuke, Tsumiyama, Ken, Imura, Shigeaki, Shiozawa, Shunichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4769545/ https://www.ncbi.nlm.nih.gov/pubmed/26922083 http://dx.doi.org/10.1186/s13075-016-0948-7 |
Ejemplares similares
-
Self-Organized Criticality Theory and the Expansion of PD-1-Positive Effector CD4 T Cells: Search for Autoantibody-Inducing CD4 T Cells
por: Miyazaki, Yumi, et al.
Publicado: (2013) -
Self-Organized Criticality Theory of Autoimmunity
por: Tsumiyama, Ken, et al.
Publicado: (2009) -
Pragmatic randomised controlled trial of very early etanercept and MTX versus MTX with delayed etanercept in RA: the VEDERA trial
por: Emery, Paul, et al.
Publicado: (2020) -
A variant of death-receptor 3 associated with rheumatoid arthritis interferes with apoptosis-induction of T cell
por: Hashiramoto, Akira, et al.
Publicado: (2018) -
Identification of 7 Proteins in Sera of RA Patients with Potential to Predict ETA/MTX Treatment Response
por: Obry, Antoine, et al.
Publicado: (2015)